COVID-19 patients with severe or critical symptoms are often treated with corticosteroids, per
contemporary guidelines. Due to their immunosuppressive and immunomodulatory …

Background The global pandemic caused by severe acute respiratory syndrome
coronavirus 2 resulted in a large burden of critically ill patients, a population with an …

Objective To assess the efficacy of corticosteroids in patients with coronavirus disease 2019
(COVID-19). Methods A multicentre observational study was performed from 22 February …

Introduction Corticosteroids are a component of the standard therapy for patients with
coronavirus disease 2019 (COVID-19) because of the immunological dysregulation and …

Background: Corticosteroids are part of the treatment guidelines for COVID-19 and have
been shown to improve mortality. However, the impact corticosteroids have on the …

Objectives Use of corticosteroids is common in the treatment of coronavirus disease 2019,
but clinical effectiveness is controversial. We aimed to investigate the association of …

Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …

Objectives To assess whether high-compared with low-dose corticosteroids started upon
hospitalization reduce mortality in patients with severe COVID-19 pneumonia or in …

Anti-inflammatory drugs such as corticosteroids may beneficially modulate the host
inflammatory response to coronavirus disease 2019 (COVID-19) pneumonia. The aim of this …

Background Corticosteroids are commonly used as adjuvant therapy for acute respiratory
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …